Blue Eagle Lithium
High Times
Home > Boards > US OTC > Biotechs >

Inspyr Therapeutics Inc. (NSPX)

NSPX RSS Feed
Add NSPX Price Alert      Hide Sticky   Hide Intro
Moderator: Law of Averages
Search This Board: 
Last Post: 10/22/2018 8:39:27 PM - Followers: 53 - Board type: Free - Posts Today: 0





2511 N Loop 1604 W
Suite 204
San Antonio, TX 78258
Phone: 210-479-8112
Email: info@genspera.com

Website: http://www.genspera.com

Craig Dionne President, CEO, CFO
Russell Richerson COO, Secretary
 


Shares Outstanding 27,392,100 a/o Mar 09, 2014
Float Not Available
Authorized Shares 80,000,000 a/o Jun 30, 2009

Latest Report Mar 31, 2014 10-Q
CIK 0001421204
Fiscal Year End 12/31
 

About GenSpera

GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera’s lead drug candidate, G-202, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. G-202 is therefore expected to have potential efficacy in a wide variety of tumor types.

G-202 Phase II clinical trials are underway in both hepatocellular carcinoma and glioblastoma patients.

Business Description

We are a biotechnology company focused on the discovery and development of pro-drug cancer therapeutics, an emerging medical science. A pro-drug is an inactive precursor of a drug that is converted into its active form only at the site of the tumor. We were incorporated as a Delaware corporation in 2003.

GenSpera Inc. (GenSpera) is a development-stage pharmaceutical company. The Company is focused on the development of prodrug cancer therapeutics for the treatment of solid tumors including prostate, liver, brain and other cancers. A prodrug is an inactive precursor of a drug that is converted into its active form only at the site of the tumor. The Company has four prodrug candidates: G-202, G-114, G-115 and G-301. The Company's primary focus is the clinical development of its compound, G-202, a therapeutic agent with a mechanism of action. G-202 is in Phase II Clinical Trial. G-114 is validated efficacy in pre-clinical animal models. Pilot toxicology is completed for G-115. G-301 is validated efficacy in pre-clinical animal models. The Company is also conducting a Phase II clinical trial to test the utility of G-202 in patients with hepatocellular carcinoma (liver cancer). As of March 27, 2013, it treated one patient in this Phase II trial.


GenSpera harnesses a novel biomedical technology platform to deliver a powerful toxin directly to tumors

  • Phase II clinical trials for lead compound, G-202, are underway in two indications:
    • Hepatocellular carcinoma, or liver cancer
    • Glioblastoma, or brain cancer
  • Experienced and motivated team drives the process:
    • Core team has extensive experience in successfully identifying and bringing oncology treatments to the clinic.
    • Scientific Advisory Board is comprised of leading researchers who are both the inventors of the technology and shareholders.
  • Technology platform supports the development of a suite of drugs targeted at different cancers, as well as other applications such as imaging.
  • Over 15 years of research at Johns Hopkins Medical Center and other renowned research centers, including the University of Copenhagen.
    • Strong intellectual property portfolio
    • No milestones or royalty payments owed to third parties.
  • Leverage the team's passion and expertise in identifying promising treatments and bringing them to the clinic.




Blue Eagle Lithium
High Times
NSPX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1172   something is gonna give wamuvoodoo 10/22/18 08:39:27 PM
#1171   Hope you make millions! Mrragu 10/22/18 07:30:22 PM
#1170   puts me at 700,000..waiting for the lift off wamuvoodoo 10/22/18 05:12:44 PM
#1169   I just picked up another three hundred plus wamuvoodoo 10/22/18 01:10:09 PM
#1168   I would suggest opening bell tomorrow, this one Floppyplants 10/22/18 03:59:11 AM
#1167   Gonna add to my pile again next week... floridaboy 10/20/18 02:24:28 PM
#1166   Either can’t sell or not sell for what Mrragu 10/20/18 12:44:59 PM
#1165   Got it thanks. robtewms 10/20/18 12:40:06 PM
#1164   Recent PR(scroll back a couple weeks on posts)shows floridaboy 10/20/18 12:37:39 PM
#1163   Why they don't sell or license the patents? robtewms 10/20/18 12:34:52 PM
#1162   Patents... floridaboy 10/20/18 12:29:38 PM
#1161   What is keeping this turd afloat? robtewms 10/20/18 12:15:00 PM
#1160   Accumulation continues heading into 2019... floridaboy 10/20/18 11:15:31 AM
#1159   Maybe Some news leakes out$$ slickinvest 10/19/18 03:38:00 PM
#1158   + 31.70% 0.0054 harmsen 10/19/18 03:22:42 PM
#1157   NSPX approaching record volume day here. I wonder Law of Averages 10/19/18 02:40:25 PM
#1156   We are getting some buys in today $$ slickinvest 10/19/18 02:29:11 PM
#1155   eyes open.... spion 10/19/18 02:13:12 PM
#1154   We need a 10q or 10k desperately. I Law of Averages 10/18/18 04:48:47 PM
#1153   Market makers squeeezing every drop of life out Mrragu 10/18/18 10:43:20 AM
#1152   I feel like floridaboy knows something that the Onthegrind2 10/17/18 10:06:50 PM
#1149   Good post... floridaboy 10/16/18 03:51:15 PM
#1148   NSPX is EXTREMELY OVERSOLD here. Its trading as TradingGems 10/16/18 03:37:19 PM
#1147   Folks following NSPX are very aware of the floridaboy 10/10/18 05:24:12 AM
#1146   Just too many cheap shares out there for Mrragu 10/09/18 05:39:44 PM
#1145   Today could get interesting... floridaboy 10/08/18 06:00:02 AM
#1144   I'm shocked NSPX isnt on the breakout boards. Law of Averages 10/06/18 10:52:52 AM
#1143   Buyers came awake at 15:40..What’s Up Doc? Mrragu 10/05/18 10:03:23 PM
#1142   I grabbed a good handful, Monday may get floridaboy 10/05/18 05:52:31 PM
#1141   Another 600k bought at the ask after you No-dough-go 10/05/18 04:23:21 PM
#1140   Some crazy late day action here. Big buys Law of Averages 10/05/18 03:50:34 PM
#1139   Another deal like the news we recently got, floridaboy 10/04/18 05:01:52 AM
#1138   What do you think could make this stock Onthegrind2 10/03/18 09:40:19 PM
#1137   Still in accumulation mode man, acquire what you floridaboy 10/02/18 04:24:29 PM
#1136   NSPX possible double bottom reversal at .0045 Law of Averages 10/02/18 10:18:59 AM
#1135   Holding on and adding to my stake in Mrragu 09/29/18 01:50:53 PM
#1134   Patience I have... floridaboy 09/29/18 12:28:18 PM
#1133   you just need patience with this money maker wamuvoodoo 09/29/18 08:58:13 AM
#1132   Gonna add to my pile next week, expecting floridaboy 09/28/18 07:35:21 PM
#1131   Some buying at end of week to add Mrragu 09/28/18 05:33:03 PM
#1130   Squeeze, squeeze, squeeze, as traders and longer term floridaboy 09/28/18 07:44:07 AM
#1129   Just bought 6800 shares at.008, want to see Onthegrind2 09/25/18 10:40:37 AM
#1128   New day dawning @ NSPX, filled with possibilities... floridaboy 09/24/18 07:01:19 AM
#1127   I hope NSPX runs past .25+ Law of Averages 09/23/18 10:08:10 PM
#1126   The countdown has begun wamuvoodoo 09/23/18 10:26:38 AM
#1125   Being accumulated at these extremely cheap pps levels. floridaboy 09/23/18 09:30:39 AM
#1124   this is the hidden GEM of all GEMS wamuvoodoo 09/22/18 11:19:30 PM
#1123   That would be very cool... floridaboy 09/22/18 01:06:02 PM
#1122   A license agreement for mipsagargin with legit pharma Mrragu 09/22/18 11:49:03 AM
#1121   One would think with a small float this Law of Averages 09/22/18 09:01:35 AM
PostSubject